Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

NASDAQ:KROS

Overview | Financials
Company Name Keros Therapeutics, Inc.
Symbol KROS
Currency USD
Price 48.02
Market Cap 1,732,748,878
Dividend Yield 0%
52-week-range 27.02 - 73
Industry Biotechnology
Sector Healthcare
CEO Dr. Jasbir S. Seehra Ph.D.
Website https://www.kerostx.com

An error occurred while fetching data.

About Keros Therapeutics, Inc.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell

Related Stocks

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

12.85 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

23.22 USD

National Research Corporation logo

National Research Corporation

NRC

23.93 USD

Morphic Holding, Inc. logo

Morphic Holding, Inc.

MORF

56.32 USD

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

37.37 USD

Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

SANA

5.93 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

14.71 USD

Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc.

TMCI

7.89 USD

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

1.31 USD

Financials

Numbers are in millions USD

Numbers are in millions USD